Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease

被引:0
|
作者
Zhang, Yizhi [1 ,2 ]
Chen, Yu [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Dept Liver Dis 4, Difficult & Complicated Liver Dis & Artificial Li, 8 Xi Tou Tiao,Youanmenwai St, Beijing 100069, Peoples R China
[2] Beijing Municipal Key Lab Liver Failure & Artific, Beijing 100069, Peoples R China
关键词
Autophagy; Lipophagy; Mitophagy; Reticulophagy; Non-alcoholic fatty liver disease; ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL PERMEABILITY TRANSITION; LIPID DROPLETS; INSULIN-RESISTANCE; QUALITY-CONTROL; SELECTIVE AUTOPHAGY; HEPATIC STEATOSIS; OXIDATIVE STRESS; MECHANISMS; ASSOCIATION;
D O I
10.1097/CM9.0000000000002263
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a disorder of lipid metabolism. The lipotoxic intermediates of lipid metabolism cause mitochondrial dysfunction and endoplasmic reticulum stress. Organelle-specific autophagy is responsible for the removal of dysfunctional organelles to maintain intracellular homeostasis. Lipophagy contributes to lipid turnover by degrading lipid droplets. The level of autophagy changes during the course of NAFLD, and the activation of hepatocyte autophagy might represent a method of treating NAFLD.
引用
收藏
页码:1673 / 1681
页数:9
相关论文
共 50 条
  • [1] Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease
    Zhang Yizhi
    Chen Yu
    中华医学杂志英文版, 2022, 135 (14) : 1673 - 1681
  • [2] The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
    Shen, Qiaohui
    Yang, Ming
    Wang, Song
    Chen, Xingyu
    Chen, Sulan
    Zhang, Rui
    Xiong, Zhuang
    Leng, Yan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [3] Autophagy and Non-Alcoholic Fatty Liver Disease
    Lavallard, Vanessa J.
    Gual, Philippe
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [4] Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease
    Chen, Chien-Chih
    Hsu, Li-Wen
    Chen, Kuang-Den
    Chiu, King-Wah
    Chen, Chao-Long
    Huang, Kuang-Tzu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [5] The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
    Grefhorst, Aldo
    van de Peppel, Ivo P.
    Larsen, Lars E.
    Jonker, Johan W.
    Holleboom, Adriaan G.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [6] The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease
    Del Ben, Maria
    Polimeni, Licia
    Baratta, Francesco
    Pastori, Daniele
    Angelico, Francesco
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (01) : 88 - 95
  • [7] Current treatment of non-alcoholic fatty liver disease
    Ahmed, Mohamed H.
    Byrne, Christopher D.
    DIABETES OBESITY & METABOLISM, 2009, 11 (03): : 188 - 195
  • [8] Non-alcoholic fatty liver disease and liver secretome
    Khan, Muhammad Sohaib
    Lee, Choongho
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963
  • [9] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6
  • [10] Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease
    Lakhani, Hari Vishal
    Sharma, Dana
    Dodrill, Michael W.
    Nawab, Athar
    Sharma, Nitin
    Cottrill, Cameron Lee
    Shapiro, Joseph I.
    Sodhi, Komal
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2018, 15 (14): : 1591 - 1599